Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00794768
First received: November 19, 2008
Last updated: June 19, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2003
  Primary Completion Date: July 2003 (Final data collection date for primary outcome measure)